Cargando…

The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils

PPARγ agonists can either enhance or inhibit eosinophil migration, which is a sum of directional migration (chemotaxis) and random cell movement (chemokinesis). To date, the effects of PPAR agonists on chemokinesis have not been examined. This study investigates the effects of PPARα, δ, and γ agonis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Steven G., Imaoka, Haruki, Punia, Neha, Irshad, Anam, Janssen, Luke L., Sehmi, Roma, Gauvreau, Gail M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395269/ https://www.ncbi.nlm.nih.gov/pubmed/22966220 http://dx.doi.org/10.1155/2012/235231

Ejemplares similares

Integrins are Mechanosensors That Modulate Human Eosinophil Activation
por: Ahmadzai, Mustafa, et al.
Publicado: (2015)

The Cycling of Intracellular Calcium Released in Response to Fluid Shear Stress Is Critical for Migration-Associated Actin Reorganization in Eosinophils
por: Son, Kiho, et al.
Publicado: (2021)

IL-4 and IL-13 regulate TLR expression and eosinophil-basophil differentiation of cord blood CD34(+) progenitor cells
por: Reece, Pia, et al.
Publicado: (2014)

IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation of Cord Blood CD34(+) Progenitor Cells
por: Reece, Pia, et al.
Publicado: (2014)

Interleukin-25 and eosinophils progenitor cell mobilization in allergic asthma
por: Tang, Wei, et al.
Publicado: (2018)

Eosinophil Lineage-Committed Progenitors as a Therapeutic Target for Asthma
por: Salter, Brittany M., et al.
Publicado: (2021)

Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD
por: Salter, Brittany M., et al.
Publicado: (2016)

Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration
por: Kim, Min Kyung, et al.
Publicado: (2019)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Lung-Homing of Endothelial Progenitor Cells and Airway Vascularization Is Only Partially Dependant on Eosinophils in a House Dust Mite-Exposed Mouse Model of Allergic Asthma
por: Sivapalan, Nirooya, et al.
Publicado: (2014)

Abnormal eosinophils with immature eosinophilic granules in chronic myeloid leukemia in accelerated phase
por: Cai, Jennifer, et al.
Publicado: (2021)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
por: Zhan, Chen, et al.
Publicado: (2022)

In Vitro Effects of Budesonide on Eosinophil-Basophil Lineage Commitment
por: Cyr, Michael M, et al.
Publicado: (2008)

Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells
por: Allakhverdi, Zoulfia, et al.
Publicado: (2013)

Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017)

Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists
por: Dunning, Kylie R., et al.
Publicado: (2014)

Nebulized PPARγ Agonists: A Novel Approach to Augment Neonatal Lung Maturation and Injury Repair
por: Morales, Edith, et al.
Publicado: (2014)

PPAR Agonists and Cardiovascular Disease in Diabetes
por: Calkin, Anna C., et al.
Publicado: (2008)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma
por: Salter, Brittany M., et al.
Publicado: (2016)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008)

Sounding the alarmins—The role of alarmin cytokines in asthma
por: Gauvreau, Gail M., et al.
Publicado: (2022)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010)

AMPK-Dependent Metabolic Regulation by PPAR Agonists
por: Lee, Woo Hyung, et al.
Publicado: (2010)

PPAR Agonists and Metabolic Syndrome: An Established Role?
por: Botta, Margherita, et al.
Publicado: (2018)

PPAR Agonists for the Prevention and Treatment of Lung Cancer
por: Lakshmi, Sowmya P., et al.
Publicado: (2017)

PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)

Morphological and biomechanical characterization of immature and mature nasoseptal cartilage
por: Jessop, Zita M., et al.
Publicado: (2019)

Isoflavone Changes in Immature and Mature Soybeans by Thermal Processing
por: Qu, Shanshan, et al.
Publicado: (2021)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

Priming with a gonadotropin-releasing hormone agonist before immature oocyte retrieval may improve maturity of oocytes and outcome in in vitro maturation (IVM) cycle: a case report
por: Smirnova, A., et al.
Publicado: (2021)

The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells
por: Ciavarella, Carmen, et al.
Publicado: (2023)

Agonist of PPAR-γ Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1
por: Yang, Pingli, et al.
Publicado: (2019)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

Role of PPARα and Its Agonist in Renal Diseases
por: Cheng, Ching-Feng, et al.
Publicado: (2010)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_79disv4a035hn435brqaqan6ur